Approval · Notice of Compliance 24647 · 2020
PERSERIS: Notice of Compliance 24647
Issued November 19, 2020
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 24647
- Date
- November 19, 2020
- Company
- Hls Therapeutics IncEtobicoke, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Other
Products in this notice
Medicinal ingredients
- RISPERIDONE 90 MG per SYR
- RISPERIDONE 120 MG per SYR